loader
Please Wait
Applying Filters...
menu
    • menu

    Setid A2d3bd73 F3af 4ea5 A57c 66b0004cfe4f Applno 21887 Form Capsule Oral Dosage 60mg - Drug Product Composition: Orlistat

    Menu

    Orlistat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 508Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21887 / DOSAGE - CAPSULE;ORAL - 60MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ORLISTAT(UNII: 95M8R751W8)
    (ORLISTAT - UNII:95M8R751W8)     		ORLISTAT60mg

    Inactive Ingredients

    Ingredient Name
    Haleon US Holdings LLC
    FD&C BLUE NO. 2(L06K8R7DQK)
    FERROUS OXIDE(G7036X8B5H)
    GELATIN, UNSPECIFIED(2G86QN327L)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    POVIDONE, UNSPECIFIED(FZ989GH94E)
    SODIUM LAURYL SULFATE(368GB5141J)
    SODIUM STARCH GLYCOLATE TYPE A(H8AV0SQX4D)
    TALC(7SEV7J4R1U)
    TITANIUM DIOXIDE(15FIX9V2JP)